Return On Equity
-22%
Trailing 12 months · Through 30 Sep 2022
AlerisLife Inc. financial metrics
Period Q3 2022 · Filed 02 Nov 2022
Key metrics snapshot
Return On Assets
-10%
Trailing 12 months · Through 30 Sep 2022
Current Ratio
1.58x
Period-end balance · Through 30 Sep 2022
YoY relative change: +4.4%
Profitability
| Metric | Latest value | YoY relative change |
|---|---|---|
| Return On Equity |
-22%
Trailing 12 months · 30 Sep 2022
|
|
| Return On Assets |
-10%
Trailing 12 months · 30 Sep 2022
|
Financial Health
| Metric | Latest value | YoY relative change |
|---|---|---|
| Current Ratio |
1.58x
Period-end balance · 30 Sep 2022
|
+4.4% |
Share Metrics
| Metric | Latest value | YoY relative change |
|---|---|---|
| Entity Common Stock, Shares Outstanding |
32,609,007
Period-end balance · 28 Oct 2022
|
+2.7% |
| Common Stock, Shares, Outstanding |
32,609,009
Period-end balance · 30 Sep 2022
|
+2.7% |
| Common Stock, Value, Issued |
$326,000
Period-end balance · 30 Sep 2022
|
+2.5% |
| Weighted Average Number of Shares Outstanding, Basic |
31,875,000
Reported period · 30 Sep 2022
|
+0.81% |
| Weighted Average Number of Shares Outstanding, Diluted |
31,875,000
Reported period · 30 Sep 2022
|
+0.81% |
Supporting Metrics
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY relative change |
|---|---|---|
| Accounts Payable, Current |
$16,367,000
Period-end balance · 30 Sep 2022
|
-0.44% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax |
$33,000
Period-end balance · 30 Sep 2022
|
-103% |
| Additional Paid in Capital |
$462,144,000
Period-end balance · 30 Sep 2022
|
+0.29% |
| Assets |
$382,538,000
Period-end balance · 30 Sep 2022
|
+3.3% |
| Assets, Current |
$199,323,000
Period-end balance · 30 Sep 2022
|
+7.7% |
| Cash and Cash Equivalents, at Carrying Value |
$79,126,000
Period-end balance · 30 Sep 2022
|
-1.3% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$101,434,000
Period-end balance · 30 Sep 2022
|
-3.3% |
| Common Stock, Par or Stated Value Per Share |
0.01
Period-end balance · 30 Sep 2022
|
0% |
| Common Stock, Shares Authorized |
75,000,000
Period-end balance · 30 Sep 2022
|
0% |
| Common Stock, Shares, Issued |
32,609,009
Period-end balance · 30 Sep 2022
|
+2.7% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$38,794,000
Trailing 12 months · 30 Sep 2022
|
-133% |
| Depreciation |
$10,967,000
Trailing 12 months · 30 Sep 2022
|
+1.9% |
| Earnings Per Share, Basic |
-1
Trailing 12 months · 30 Sep 2022
|
-137% |
| Earnings Per Share, Diluted |
-1
Trailing 12 months · 30 Sep 2022
|
-131% |
| General and Administrative Expense |
$71,563,000
Trailing 12 months · 30 Sep 2022
|
-18% |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest |
$37,464,000
Trailing 12 months · 30 Sep 2022
|
+18% |
| Income Tax Expense (Benefit) |
$139,000
Trailing 12 months · 30 Sep 2022
|
|
| Interest Expense |
$4,061,000
Trailing 12 months · 30 Sep 2022
|
+121% |
| Liabilities and Equity |
$382,538,000
Period-end balance · 30 Sep 2022
|
+3.3% |
| Liabilities, Current |
$126,131,000
Period-end balance · 30 Sep 2022
|
+3.1% |
| Marketable Securities, Current |
$10,890,000
Period-end balance · 30 Sep 2022
|
-44% |
| Operating Income (Loss) |
$32,776,000
Trailing 12 months · 30 Sep 2022
|
-151% |
| Operating Lease, Liability, Current |
$501,000
Period-end balance · 30 Sep 2022
|
+20% |
| Operating Lease, Liability, Noncurrent |
$5,331,000
Period-end balance · 30 Sep 2022
|
-44% |
| Operating Lease, Right-of-Use Asset |
$5,796,000
Period-end balance · 30 Sep 2022
|
-39% |
| Other Assets, Noncurrent |
$8,155,000
Period-end balance · 30 Sep 2022
|
-19% |
| Other Liabilities, Noncurrent |
$227,000
Period-end balance · 30 Sep 2022
|
-33% |
| Property, Plant and Equipment, Gross |
$293,327,000
Period-end balance · 30 Sep 2022
|
+6% |
| Property, Plant and Equipment, Net |
$162,785,000
Period-end balance · 30 Sep 2022
|
+3.7% |
| Retained Earnings (Accumulated Deficit) |
$308,107,000
Period-end balance · 30 Sep 2022
|
-14% |
| Stockholders' Equity Attributable to Parent |
$154,330,000
Period-end balance · 30 Sep 2022
|
-20% |
Comparisons, sources and research notes
Sources and sharing
AlerisLife Inc. Financial Facts
- Context
- Latest metrics period: Q3 2022
- Latest reported value
- Return On Equity -22%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Tracking and update notes
Why revisit this company facts page
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
- Latest source-backed update
- Latest metrics period Q3 2022
- Why come back
- Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
- Current latest metrics period: Q3 2022.
- Most recent SEC facts end date on this page: 28 Oct 2022.
- Save this filer to return when the next filing-backed metric period changes the picture.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest update for AlerisLife Inc.
Latest financial period: Q3 2022. Reopen this facts page to verify the newest reported period against the prior baseline.
Update date
02 Nov 2022
Page type
Company facts
Latest period
Q3 2022
SEC-backed company facts were refreshed from filings filed on 02 Nov 2022.
Benchmark Context
How Return On Equity compares
Return On Equity does not yet have enough prior-period data for a historical comparison on this page.
Compared with
Compared with AlerisLife Inc.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.
Why this is notable
Return On Equity already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.
- Latest comparable period on this page: Q3 2022.
- Peer context will appear when enough companies report a comparable value for this metric.
- Open the metric history first if you want to verify the exact period-to-period change.
Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.
Filing notes and source
Key facts
- AlerisLife Inc. financial facts use SEC filings; any third-party reference is labeled separately.
- Latest metrics period on this page: Q3 2022.
- Headline metric: Return On Equity -22%.
Change
- Comparable YoY change is unavailable for this metric.
- Most recent SEC facts end date: 28 Oct 2022.
Research use
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Metric cards link to SEC history; a third-party reference may use a different or unverified reporting period.
Evidence
Based on latest 10-Q/10-K
View source filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest financial snapshot (2022-10-28) highlights Return On Equity -21.7%, Return On Assets -10.0%, and Current Ratio 1.58x.
Valuation Snapshot
SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.
No market comparison
No market comparison
Low confidence
Fair value per share
$34.69
Market price
n/a
PEG ratio
n/a
Enterprise value
$1.19B
Equity value
$1.11B
DCF fair value scenarios
Bear
$25.26
- Growth
- 1%
- Discount
- 11%
- Terminal
- 2%
Base
$34.69
- Growth
- 4%
- Discount
- 10%
- Terminal
- 2.5%
Bull
$49.54
- Growth
- 7%
- Discount
- 9%
- Terminal
- 3%
Base growth: DCF Growth Assumption.
Key valuation metrics
EV/Revenue
n/a
Market price market EV / SEC revenue
Market enterprise value is unavailable
EV/EBITDA
n/a
Market price market EV / SEC EBITDA
Market enterprise value is unavailable
P/E
n/a
Market price market price / SEC EPS
Market cap is unavailable
P/S
n/a
Market price market cap / SEC revenue
Market cap is unavailable
P/B
n/a
Market price market cap / SEC equity
Market cap is unavailable
PEG
n/a
P/E / DCF Growth Assumption
P/e or positive growth is unavailable
Core assumptions
- Projection
- 5 years
- FCF growth
- 4%
- Discount rate
- 10%
- Terminal growth
- 2.5%
SEC fact inputs
- DCF base FCF
- $81.37M
- Trailing SEC FCF
- Reported FCF
- $81.37M
- Net income
- $29.92M
- EBITDA
- $20.68M
- Cash
- $79.13M
- Debt
- n/a
- Equity
- $154.33M
- Shares
- 31,875,000
Data confidence notes
- Dcf base free cash flow: dcf base starts from trailing sec free cash flow
- Dcf base free cash flow: recent annual free cash flow history is thin
- Dcf base free cash flow: trailing free cash flow is not positive
- Dcf confidence is low for this sec-only free cash flow estimate
- Ticker missing for issuer
- Debt missing: equity value treats debt as 0
- Base free cash flow is negative; dcf output is mechanically computed but high risk
- Peg unavailable: market price is missing
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
32.4/100
Weak Confidence low
Return On Equity
-22%
Metric score 0.0/100
Return On Assets
-10%
Metric score 0.0/100
Financial Health
- Current Ratio
- 1.58x
Strengths
Current Ratio
Watchpoints
Return On Equity and Return On Assets
Calculation methodology and other links
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- Operating Income / Revenues using matching TTM or quarter periods; basis shown per metric
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- Revenues YoY using available TTM or quarter comparison; basis shown per metric
- Net Income YoY using available TTM or quarter comparison; basis shown per metric
CIK / security context first